Q4 FY26Published 14 May 2026Call held 14 May 2026
CAPLIPOINT Q4 FY26 Earnings Call Transcript & Analysis
Revenue₹2,300 cr+112% YoY
Revenue ₹2,300 cr (+112% YoY). Revenue doubled to INR 2,300 crores in FY26.
Read full transcript & analysis
Earnings calls
Caplin Point Laboratories Limited concall ledger
Every earnings call for CAPLIPOINT — management tone, guidance, KPIs and promise tracking, quarter by quarter.
CAPLIPOINT · 5 transcripts · Healthcare · latest Q4 FY26Caplin Point Laboratories Limited has 5 earnings calls on record here, a Healthcare company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
Q3 FY26Published 05 Feb 2026Call held 05 Feb 2026
CAPLIPOINT Q3 FY26 Earnings Call Transcript & Analysis
EBITDA Margin38.5%PAT₹477 cr
EBITDA Margin 38.5%; PAT ₹477 cr. Revenue grew by 10.6% Y-o-Y, total income by 11.2% Y-o-Y.
Read full transcript & analysisQ2 FY26Published 06 Nov 2025Call held 06 Nov 2025
CAPLIPOINT Q2 FY26 Earnings Call Transcript & Analysis
PAT₹311 cr+22% YoYPBT₹385.5 cr+19% YoY
PAT ₹311 cr (+22% YoY); PBT ₹386 cr (+19% YoY). H1 FY26 revenue of ₹1,098 crores, exceeding full year FY21 revenue of ₹1,085 crores.
Read full transcript & analysisQ1 FY26Published 07 Aug 2025Call held 07 Aug 2025
CAPLIPOINT Q1 FY26 Earnings Call Transcript & Analysis
PAT₹151 cr+20% YoYPAT Margin28.1%
PAT ₹151 cr (+20% YoY); PAT Margin 28.1%. Overall revenue grew 11.7% YoY to ₹533 crores.
Read full transcript & analysisQ4 FY25Published 15 May 2025Call held 15 May 2025
CAPLIPOINT Q4 FY25 Earnings Call Transcript & Analysis
Total Revenue₹2,034 cr+15% YoYPAT₹541 cr+17% YoYPAT Margin26.6%Gross Margin60.2%PBT₹671 cr
Total Revenue ₹2,034 cr (+15% YoY); PAT ₹541 cr (+17% YoY); PAT Margin 26.6%. Total revenue of ₹2,034 crores, up 15% YoY for FY25.
Read full transcript & analysis